Remdesivir may be cost saving in eligible patients during COVID-19 infections in Germany

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413692/
https://www.ncbi.nlm.nih.gov/pubmed/34493918
http://dx.doi.org/10.1007/s40274-021-07997-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413692/
https://www.ncbi.nlm.nih.gov/pubmed/34493918
http://dx.doi.org/10.1007/s40274-021-07997-6

Ejemplares similares